Rho (D) immunoglobulin (Kamada)

N/A

Report date: 2022/02/09 10:22:39

Base Information

Drug NameRho (D) immunoglobulin (Kamada)
Drug Alias NameRho(D) Immunoglobulin (Kamada)抗RhoD免疫球蛋白 (Kamada)抗D免疫球蛋白 (Kamada)Anti-D Rho immunoglobulin (Kamada)抗D Rho免疫 (Kamada) +[6] 
ClassificationBiologics > Blood components
Mechanisms of ActionBlood group Rh(D) polypeptide inhibitors
TargetsBlood group Rh(D) polypeptide
Therapy Area/IndicationsPurpura, Thrombocytopenic, IdiopathicErythroblastosis, Fetal
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesKamada
China Registration ClassN/A

Develop Information

Active CompaniesKamadaTuteur
Inactive CompaniesN/A
Active IndicationsPurpura, Thrombocytopenic, IdiopathicErythroblastosis, Fetal
Inactive IndicationsN/A

Other Information

ATC CodeJ06BB01
Related LinksN/A